# Ypsomed sells diabetes business to TecMed for CHF 420 million

Ypsomed announced the sale of its diabetes care activities to TecMed for 420 million Swiss francs, with the transaction expected to close in the second half of 2025 subject to regulatory approval.

- Type: Acquisition
- Announced: 2025-04-22
- Where: Switzerland
- Value: $470.0M (420.0M CHF)
- Status: announced
- Products: diabetes care devices, injection systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)
- [TecMed](https://endata.com/companies/84286.md) (acquirer)

## Sources

- [swissinfo.ch](https://www.swissinfo.ch/fre/ypsomed-c%c3%a8de-les-activit%c3%a9s-li%c3%a9es-au-diab%c3%a8te-%c3%a0-tecmed/89195493), 2025-04-22: "Le producteur bernois de dispositifs d'injection Ypsomed a annoncé mardi céder les activités liées au diabète à la société basée à Burgdorf et contrôlée par Willy Michel, TecMed."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.